IN8bio, Inc.INABNASDAQ
LOADING
|||
Switch Symbol:
EBITDA Over Time
Below historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-26.94M
↓ 70% below average
Average (6y)
$-15.89M
Historical baseline
Range
High:$-1.97M
Low:$-27.51M
CAGR
+54.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-26.94M | +2.0% |
| 2023 | $-27.51M | -0.3% |
| 2022 | $-27.42M | -97.7% |
| 2021 | $-13.87M | -63.7% |
| 2020 | $-8.47M | -68.1% |
| 2019 | $-5.04M | -155.6% |
| 2018 | $-1.97M | - |